---
title: "3SBio climbs 5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304219522.md"
description: "3SBio rose 5.46% to HK$14.69. Up 7.30% over five sessions and down 38.61% YTD."
datetime: "2026-11-04T06:06:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304219522.md)
  - [en](https://longbridge.com/en/news/304219522.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304219522.md)
generator: "portal-rs"
---

# 3SBio climbs 5%

3SBio (1530.HK) climbed more than **5%** in Hong Kong trading to **HK$14.69**.

The stock is up 7.30% over the past five sessions and down 38.61% year to date.

The Hang Seng Index is up 3.09% over the past five sessions and down 7.11% year to date.

The biotechnology industry index rose 7.1% over the same period.

Key drivers include the out-licensing of SSGJ-707 to Pfizer, strong R&D capabilities and undervalued Phase II clinical assets.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [01530.HK](https://longbridge.com/en/quote/01530.HK.md)

## Related News & Research

- [Citi: 2026 NRDL Negotiation Results Released; Drugmakers Say Price Cuts Mild and Manageable](https://longbridge.com/en/news/306083646.md)
- [UBS Keeps Their Buy Rating on 3SBio (TRSBF)](https://longbridge.com/en/news/303823090.md)
- [Tamil Nadu Newsprint and Papers' (NSE:TNPL) Profits Appear To Have Quality Issues](https://longbridge.com/en/news/306343812.md)
- [KNR Constructions' (NSE:KNRCON) Conservative Accounting Might Explain Soft Earnings](https://longbridge.com/en/news/306343335.md)
- [SanRex proposes to acquire Frontage Holdings for HKD 2.370 per share](https://longbridge.com/en/news/304839252.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**